Advertisement

Studies Examine Cost-Effectiveness of Maternal RSV Vaccination, Nirsevimab in Infants

0

Seasonal maternal RSV vaccination may be cost-effective, as well as nirsevimab, particularly for those with higher risks

President-Elect Trump Names His Picks to Head the CDC and FDA

0

In addition, the president-elect has chosen his nominee for surgeon general

Bird Flu Virus in Canadian Teen Shows Mutations That Could Help It Spread Among...

0
By Robin Foster HealthDay Reporter FRIDAY, Nov. 22, 2024 (HealthDay News) -- In a development that health experts have warned might come, Canadian officials report...

Woman Receives World’s First Robotic Double-Lung Transplant

0
By Carole Tanzer Miller HealthDay Reporter FRIDAY, Nov. 22, 2024 (HealthDay News) -- A 57-year-old woman with COPD has received the world's first fully robotic...

Optimal Timing of Maternal RSV Vaccine Determined to Be at Least Five Weeks Before...

0

Maternal vaccination two to three or three to four weeks before delivery linked to lower cord:maternal transfer ratios versus at least five weeks

Study Assesses Risk for 28-Day Hospitalization for Adults With RSV

0

In three databases, 4.5, 6.0, and 6.2 percent of medically attended RSV patients experienced 28-day all-cause hospitalization

Four Million Americans Could Lose Health Coverage Once ACA Credits Expire

0
By Carole Tanzer Miller HealthDay Reporter WEDNESDAY, Nov. 20, 2024 (HealthDay News) -- If Congress lets health care tax credits established during the pandemic expire,...

Surgeon General Says U.S. Smoking Rates Have Tumbled, But Not for Everyone

0
By Carole Tanzer Miller HealthDay Reporter WEDNESDAY, Nov. 20, 2024 (HealthDay News) -- Although the United States has made significant headway in curbing cigarette smoking...

President-Elect Trump to Pick Mehmet Oz to Head CMS

0

Oz worked as a heart surgeon before helming a hugely successful daytime talk show, focused on health and medicine

Metformin Use Tied to Lower Rate of Asthma Attacks

0

Further reductions seen with the use of glucagon-like peptide-1 receptor agonists